Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$1.53B |
| 2 |
Procter & Gamble
PG
|
+$1.01B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$684M |
| 4 |
Zoom
ZM
|
+$534M |
| 5 |
Chewy
CHWY
|
+$491M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.07B |
| 2 |
ServiceNow
NOW
|
+$874M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$776M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$767M |
| 5 |
Apple
AAPL
|
+$719M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.32% |
| 2 | Healthcare | 10.4% |
| 3 | Consumer Discretionary | 8.1% |
| 4 | Communication Services | 7.82% |
| 5 | Financials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Corbus Pharmaceuticals
CRBP
$165M
| $11.3M | ﹤0.01% |
44,849
+19,048
| +74% | +$3.85M |
|
1852
Invesco BulletShares 2028 Corporate Bond ETF
BSCS
$3.57B
| $11.3M | ﹤0.01% |
491,871
+47,612
| +11% | +$1.05M |
|
1853
Middlesex Water
MSEX
$1.07B
| $11.3M | ﹤0.01% |
167,881
+4,541
| +3% | +$288K |
|
1854
Arcos Dorados Holdings
ARCO
$1.75B
| $11.3M | ﹤0.01% |
2,762,747
-29,407
| -1% | -$110K |
|
1855
AMN Healthcare
AMN
$1.28B
| $11.3M | ﹤0.01% |
248,913
+86,096
| +53% | +$4.12M |
|
1856
Simpson Manufacturing
SSD
$7.91B
| $11.2M | ﹤0.01% |
133,350
-8,766
| -6% | -$646K |
|
|
AXDX
1857
DELISTED
Accelerate Diagnostics
AXDX
| $11.2M | ﹤0.01% |
74,069
+42,349
| +134% | +$4.18M |
|
|
POLY
1858
DELISTED
Plantronics, Inc.
POLY
| $11.2M | ﹤0.01% |
764,426
+540,848
| +242% | +$7.05M |
|
1859
Winnebago Industries
WGO
$885M
| $11.2M | ﹤0.01% |
168,401
+3,314
| +2% | +$169K |
|
1860
Apogee Enterprises
APOG
$876M
| $11.2M | ﹤0.01% |
485,737
+414,191
| +579% | +$8.46M |
|
|
JHY
1861
DELISTED
Nuveen High Income 2020 Target Term Fund Common Shares of Beneficial Interest
JHY
| $11.2M | ﹤0.01% |
1,199,838
-18,114
| -1% | -$166K |
|
1862
STAAR Surgical
STAA
$1.21B
| $11.2M | ﹤0.01% |
181,476
-23,201
| -11% | -$948K |
|
1863
Integer Holdings
ITGR
$4.23B
| $11.2M | ﹤0.01% |
152,626
+46,646
| +44% | +$3.39M |
|
1864
Emergent Biosolutions
EBS
$382M
| $11.1M | ﹤0.01% |
140,761
+15,714
| +13% | +$1.17M |
|
1865
Agree Realty
ADC
$9.24B
| $11.1M | ﹤0.01% |
168,618
+38,251
| +29% | +$2.44M |
|
1866
iShares MSCI France ETF
EWQ
$338M
| $11M | ﹤0.01% |
402,772
-285,482
| -41% | -$7.18M |
|
|
TEI
1867
Templeton Emerging Markets Income Fund
TEI
$315M
| $11M | ﹤0.01% |
1,405,958
+302,416
| +27% | +$2.3M |
|
|
EPZM
1868
DELISTED
Epizyme, Inc
EPZM
| $11M | ﹤0.01% |
686,569
+594,874
| +649% | +$10.4M |
|
|
ONC
1869
BeOne Medicines Ltd
ONC
$32.6B
| $11M | ﹤0.01% |
58,472
+39,247
| +204% | +$6.39M |
|
|
PRTY
1870
DELISTED
Party City Holdco Inc.
PRTY
| $11M | ﹤0.01% |
7,393,225
-2,685,698
| -27% | -$2.48M |
|
|
GBAB
1871
Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust
GBAB
$382M
| $11M | ﹤0.01% |
473,621
+46,622
| +11% | +$1.05M |
|
|
IBMI
1872
DELISTED
iShares iBonds Sep 2020 Term Muni Bond ETF
IBMI
| $11M | ﹤0.01% |
431,015
+32,535
| +8% | +$829K |
|
1873
Rocket Pharmaceuticals
RCKT
$372M
| $11M | ﹤0.01% |
524,604
-235,839
| -31% | -$4.25M |
|
1874
Nuveen Credit Strategies Income Fund
JQC
$707M
| $11M | ﹤0.01% |
1,875,674
+162,236
| +9% | +$957K |
|
1875
VanEck Biotech ETF
BBH
$398M
| $10.9M | ﹤0.01% |
67,205
+22,113
| +49% | +$3.36M |
|
Similar funds
Morgan Stanley's Q2 2020 Portfolio in Review
As of Q2 2020, Morgan Stanley held 6,941 positions worth $452B, up 23% from $368B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Morgan Stanley's Q2 2020 filing shows 185 new, 3,288 increased, 2,645 reduced and 222 closed positions. Its largest new stake was Royalty Pharma: 6,205,186 shares worth $301M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.07B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Morgan Stanley's largest Q2 2020 buy was Royalty Pharma: 6,205,186 shares worth $301M.
- Morgan Stanley added most to Block Inc in Q2 2020, an estimated $1.53B increase.
- Morgan Stanley's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.07B.
- Morgan Stanley fully exited Allergan plc in Q2 2020, selling an estimated $487M.
- Morgan Stanley's ten largest holdings make up 17% of its $452B portfolio in Q2 2020.
- Morgan Stanley opened 185 new positions and closed 222 in Q2 2020.
- Morgan Stanley's portfolio value rose 23% quarter-over-quarter to $452B.
Based on Morgan Stanley's 13F filing for Q2 2020, filed 14 Aug 2020.